SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Nutex Health, Inc. (NUTX) (CIK 0001479681) (NUTX) — Mar 2, 2011

Nutex Health, Inc. (NUTX) (CIK 0001479681)
Date: March 2, 2011 · CIK: 0001479681 · Accession: 0000000000-11-013264

AI Filing Summary & Sentiment

File numbers found in text: 000-53862

Date
March 2, 2011
Author
Not clearly detected
Form
UPLOAD
Company
Nutex Health, Inc. (NUTX) (CIK 0001479681)

Letter

March 2, 2011 John Salerno Chief Executive Officer iGambit, Inc. 1600 Calebs Path Extension, Suite 114 Hauppauge, New York 11788

Re: iGambit, Inc. Amendment No. 5 to Registrati on Statement on Form 10 Filed February 8, 2011 Form 10-K/A for Fiscal Year Ended December 31, 2009 Filed February 23, 2011 Form 10-Q/A for Fiscal Period Ended March 31, 2010 Filed February 23, 2011 Form 10-Q/A for Fiscal Period Ended June 30, 2010 Filed February 24, 2011 Form 10-Q/A for Fiscal Period Ended September 30, 2010 Filed February 23, 2011 File No. 000-53862

Dear Mr. Salerno: We have completed our review of your fili ngs and do not have any further comments at this time. Sincerely, /s/ H. Christopher Owings H. Christopher Owings Assistant Director cc: Joel D. Mayersohn, Esq.

Show Raw Text
March 2, 2011
 John Salerno Chief Executive Officer  iGambit, Inc. 1600 Calebs Path Extension, Suite 114 Hauppauge, New York  11788

Re:  iGambit, Inc.
Amendment No. 5 to Registrati on Statement on Form 10
Filed February 8, 2011 Form 10-K/A for Fiscal Year Ended December 31, 2009 Filed February 23, 2011 Form 10-Q/A for Fiscal Period Ended March 31, 2010 Filed February 23, 2011 Form 10-Q/A for Fiscal Period Ended June 30, 2010 Filed February 24, 2011 Form 10-Q/A for Fiscal Period Ended September 30, 2010 Filed February 23, 2011
File No. 000-53862

Dear Mr. Salerno:
We have completed our review of your fili ngs and do not have any further comments at
this time.
Sincerely,
        /s/ H. Christopher Owings
 H. Christopher Owings  Assistant Director
 cc:  Joel D. Mayersohn, Esq.